| 
Results for cytos. Search took 0.16 seconds.
Seen that? - Gilead wrestles with Roche for Tamiflu rights
in The Biotech Weblog, on October 9, 2009
...rope with an orphan drug status. Further [...] Read More Novartis Acquires Rights to Cytos' Smoking Vaccine at The Biotech Weblog Novartis ...
Cytos Biotech's Allergy Drug Showing Promise in Clinical Trials
in Allergies, on July 4, 2007
... Cytos Biotechnology AG 's CYT003-QbG10 is an immunotherapeutic product candidate currently in development for the treatment of allergic diseases. This allergy product have previously shown s...
Novartis Acquires Rights to Cytos' Smoking Vaccine
in The Biotech Weblog, on April 26, 2007
...s acquired worldwide exclusive rights to a novel vaccine candidate against nicotine addiction from Cytos Biotechnology AG for up to 600 million Swiss francs (US$500 million; €366 million) for the ex...
Cytos' Allergy Vaccine Shows Long-Term Efficacy
in Allergies, on April 29, 2006
...es? Hang on, there's hope for a long-term treatment: a vaccine being developed is on track .
Cytos Biotechnology AG announced
today positive follow-up results from its phase IIa study with CYT...